Optimizing therapy of seizures in stroke patients

Neurology

Volumn 67, Issue 12 SUPPL. 4, 2006, Pages

  Ryvlin, Philippe ^a,b   Montavont, Alexandra ^a   Nighoghossian, Norbert ^a  

^a UNIVERSITÉ LYON 1   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; DICOUMAROL; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; UROKINASE; VALPROIC ACID; WARFARIN; ZONISAMIDE;

BRAIN ISCHEMIA; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG RELEASE; DRUG RETENTION; DRUG WITHDRAWAL; EPILEPSY; HUMAN; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE; STROKE PATIENT; TREATMENT OUTCOME;

EID: 33845713976     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.12_suppl_4.s3     Document Type: Review

References (132)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota; 1935-1984. Epilepsia 1993;34:453-468.
2. Forsgren L, Bucht G, Eriksson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population based study. Epilepsia 1996;37:224-229.
3. Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975;16:61-66.
4. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004;62(suppl 2):S24-29.
5. Davenport RJ, Dennis MS, Wellwood I, et al. Complications after acute stroke. Stroke 1996;27:415-426.
6. Blum DE, Eskola J, Bortz JJ, Fisher RS. Patient awareness of seizures. Neurology 1996;47:260-264.
7. Lee H, Lerner A. Transient inhibitory seizures mimicking crescendo TIAs. Neurology 1990;40:165-166.
8. Kaplan PW. Focal seizures resembling transient ischemic attacks due to subclinical ischemia. Cerebrovasc Dis 1993;3:241-243.
9. Baquis GD, Pessin MS, Scott RM. Limb shaking - a carotid TIA. Stroke 1985;16:444-448.
10. Yanagihara T, Piepgras DG, Klass DW. Repetitive involuntary movement associated with episodic cerebral ischemia. Ann Neurol 1985;18:244-250.
11. Tatemichi TK, Young WL, Prohovnik I, et al. Perfusion insufficiency in limb-shaking transient ischemic attacks. Stroke 1990;21:341-347.
12. Klempen NL, Jamardhan V, Schwartz RB, Stieg PE. Shaking limb transient ischemic attacks: unusual presentation of carotid artery occlusive disease: report of two cases. Neurosurgery 2002;51:483-487.
13. Carrera E, Michel P, Despland PA, et al. Continuous assessment of electrical epileptic activity in acute stroke. Neurology 2006;67:99-104.
14. Lamy C, Domigo V, Semah F, et al. Early and late seizures after cryptogenic stroke in young adults. Neurology 2003;60:400-404.
15. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000;57:1617-1622.
16. Burn J, Dennis M, Bamford J, et al. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997;315:1582-1587.
17. Giroud M, Gras P, Fayolle H, et al. Early seizures after acute stroke: a study of 1640 cases. Epilepsia 1994;35:959-964.
18. Lancman ME, Golimstok A, Norscini J, Granillo R. Risk factors for developing seizures after a stroke. Epilepsia 1993;34:141-143.
19. Lossius MI, Ronning OM, Slapo GD, Mowinckel P, Gjerstad L. Post-stroke epilepsy: occurrence and predictors - a long-term prospective controlled study (Akershus Stroke Study). Epilepsia 2005;46:1246-1251.
20. Benbir G, Ince B, Bozluolcay M. The epidemiology of post-stroke epilepsy according to stroke subtypes. Acta Neurol Scand 2006;114:8-12.
21. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology 1996;46:350-355.
22. Arboix A, Comes E, Massons J, et al. Prognostic value of very early seizures for in-hospital mortality in atherothrombotic infarction. Eur Neurol 2003;50:78-84.
23. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001;57:200-206.
24. Kraus JA, Berlit P. Cerebral embolism and epileptic seizures - the role of the embolic source. Acta Neurol Scand 1998;97:154-158.
25. Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke. Arch Neurol 1990;47:157-160.
26. Lo YK, Yiu CH, Hu HH, Su MS, Laeuchli SC. Frequency and characteristics of early seizures in Chinese acute stroke. Acta Neurol Scand 1994;90:83-85.
27. Gupta SR, Naheedy MH, Elias D, Rubino FA. Postinfarction seizures. A clinical study. Stroke 1988;19:1477-1481.
28. Cocito L, Favale E, Reni L. Epileptic seizures in cerebral arterial occlusive disease. Stroke 1982;13:189-195.
29. Camillo C, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004;35:1769-1775.
30. Afsar N, Kaya D, Aktan S, Canan AB. Stroke and status epilepticus: stroke type, type of status epilepticus, and prognosis. Seizure 2003;12:23-27.
31. Velioglu SK, Ozmenoglu M, Boz C, Alioglu Z. Status epilepticus after stroke. Stroke 2001;32:1169-1172.
32. Rumbach L, Sablot D, Berger E, et al. Status epilepticus in stroke. Report on a hospital-based stroke cohort. Neurology 2000;54:350-354.
33. Ferro JM, Correia M, Rosas MJ, et al, for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group (VENO-PORT). Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 2003:15;78-83.
34. Rhoney DH, Tipps LB, Murry KR, et al. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid haemorrhage. Neurology 2000;55:258-265.
35. Pinto NA, Canhao P, Ferro JM. Seizures at the onset of subarachnoid haemorrhage. J Neurol 1996;243:161-164.
36. Ferro JM, Pinto F. Poststroke epilepsy: epidemiology, pathophysiology and management. Drugs Aging 2004;21:639-653.
37. Claassen J, Peery S, Kreiter KT, et al. Predictors and clinical impact of epilepsy after subrachnoid hemorrhage. Neurology 2003;60:208-214.
38. Richardson EP, Dodge PR. Epilepsy in cerebral vascular disease: a study of the incidence and nature of seizures in 104 consecutive autopsy-proven cases of cerebral infarction or hemorrhage. Epilepsia 1954;3:49-74.
39. Lesser RP, Luders H, Dinner DS, Morris HH. Epileptic seizures due to thrombotic and embolic cerebrovascular disease in older patients. Epilepsia 1985;26:622-630.
40. Mohr JP, Caplan LR, Melski JW, et al. The Harvard cooperative stroke registry: a prospective registry. Neurology 1978;28:754-762.
41. Meyer JS, Charney JZ, Rivera VM, Mathew NT. Cerebral embolizaion: prospective analysis of 42 cases. Stroke 1971;2:541-554.
42. De Carolis P, D'Alessandro RD, Ferrara R, Andreoli A. Late seizures in patients with internal carotid and middle cerebral artery occlusive disease following ischaemic events. J Neurol Neurosurg Psychiatry 1984;47:1345-1347.
43. Bogousslavsky JL, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
44. Kittner SJ, Sharkness CM, Price TR, et al. Infarcts with a cardiac source of embolism in the NINCDS Stroke Data Bank: historical features. Neurology 1990;40:281-284.
45. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke 1997;28:1590-1594.
46. Benetes C, Pimentel J, Ferro JM. Epileptic seizures following subcortical infarcts. Cerebrovasc Dis 2001;12:331-334.
47. De Reuck J, Goethals M, Vonck K, Van Maele G. Clinical predictors of late-onset seizures and epilepsy in patients with cerebrovascular disease. Eur Neurol 2005;54:68-72.
48. Heuts-van Raak L, Lodder J, Kessels F. Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure 1996;5:185-194.
49. Arboix A, Comes E, Massons J, Garcia L, Oliveres M. Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 1996;47:1429-1435.
50. Pohlmann-Eden B, Fatar M, Hennerici M. The preserved cortical island sigh is highly predictive of postischemic seizures. Cerebrovasc Dis 2001;12:282.
51. Reith J, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Seizures in acute stroke:predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 1997;28:1585-1589.
52. Devuyst G, Karapanayiotides T, Hottinger I, Van Melle G, Bogousslavsky J. Prodromal and early epileptic seizures in acute stroke: does higher serum cholesterol protect? Neurology 2003;61:249-252.
53. Cordonnier C, Henon H, Derambure P, Pasquier F, Leys D. Influence of pre-existing dementia on the risk of post-stroke epileptic seizures. J Neurol Neurosurg Psychiatry 2005;76:1649-1653.
54. Shinton RA, Gill JS, Melnick SC, Gupta AK, Beevers DG. The frequency, characteristics and prognosis of epileptic seizures at the onset of stroke. J Neurol Neurosurg Psychiatry 1988;51:273-276.
55. Vernino S, Brown RD, Sejvar JJ, et al. Cause-specific mortality after first cerebral infarction: a population-based study. Stroke 2003;34:1828-1832.
56. Davalos A, de Cendra E, Molins A, et al. Epileptic seizures at the onset of stroke. Cerebrovasc Dis 1992;2:327-331.
57. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003;60:1441-1446.
58. Bogousslavsky J, Martin R, Regli F, Despland PA, Bolyn S. Persisting worsening of stroke sequelae after delayed seizures. Arch Neurol 1992;49:385-388.
59. Paolucci S, Silvestri G, Lubich S, et al. Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia 1997;38:266-270.
60. De Reuck J, Claeys I, Martens S, et al. Computed tomographic changes of the brain and clinical outcome of patients with seizures and epilepsy after an ischaemic hemispheric stroke. Eur J Neurol 2006;13:402-407.
61. De Reuck J, De Clerck M, Van Maele G. Vascular cognitive impairment in patients with late-onset seizures after an ischemic stroke. Clin Neurol Neurosurg 2006;108:632-637.
62. Waterhouse EJ, Vaughan JK, Barnes TY, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 1998;29:175-183.
63. Cleary P, Shorvon S, Tallis R. Late onset seizures as a predictor of subsequent stroke. Lancet 2004;363:1184-1186.
64. Shinton RA, Gill JS, Zezulka AV, Beevers DG. The frequency of epilepsy preceding stroke. Case-control study in 230 patients. Lancet 1987;1:11-13.
65. Broderick JP, Adams Jr HP, Barsan W et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30:905-915.
66. Adams Jr HP, Adams RJ, Brott T et al. Stroke Council of the American Stroke Asoociation. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
67. Hack W, Kaste M, Bogousslavsky J, et al. European Stroke Initiative recommendations for stroke management: update 2003. Cerebrovasc Dis 2003;16:311-337.
68. Kwan J, Guenther A. Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database Syst Rev 2006;3:CD005501.
69. Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36:583-587.
70. Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev 2001;4:1-13.
71. Chadwick D. Seizures and epilepsy after traumatic brain injury. Lancet 2000;355:334-336.
72. Calabresi P, Marti M, Picconi B, et al. Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Exp Neurol 2003;182:461-469.
73. Boxer PA, Cordon JJ, Mann ME, et al. Comparison of phenytoin with noncompetitive N-methyl-D-aspartate anatagonists in a model of focal brain ischemia in the rat. Stroke 1990;21;III47-51.
74. Rataud J, Debarnot F, Mary V, Pratt J, Stutzmann JM. Comparative study of voltage sensitive sodium channel blockers in focal ischemia and electric convulsions in rodents. Neurosci Lett 1994;172:19-23.
75. Schwartz-Bloom RD, McDonough KJ, Chase PJ, et al. Long-term neuroprotection by benzodiazepine full versus partial agonists after transient cerebral ischemia in the gerbil. J Cereb Blood Flow Metab 1998;18:548-558.
76. Wiard RP, Dickerson MC, Beek O, Norton R, Cooper BR. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke 1995;26:466-472.
77. Crumrine RC, Bergstrand K, Cooper AT, Faison WL, Cooper BR. Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke 1997;28:2230-2236.
78. Shuaib A, Mahmood RH, Wishart T, et al. Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study. Brain Res 1995;702:199-206.
79. Lee YS, Yoon BW, Roh JK. Neuroprotective effects of lamotrigine enhanced by flunarizine in gerbil global ischemia. Neurosci Lett 1999;265:215-217.
80. Smith SE, Meldrum BS. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke 1995;26:1117-1121.
81. Inglefield JR, Perry JM, Schwarz RD. Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus. Hippocampus 1995;5:460-468.
82. Xu Chen W, Yi Y, Qiu L, Shuaib A. Neuroprotective activity of tiagabine in a focal model of cerebral ischemia. Brain Res 2000;874:75-77.
83. Yang Y, Li Q, Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology 2000;39:881-888.
84. Minato H, Kikuta C, Fujtani B, Masuda Y. Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats. Epilepsia 1997;38:228-234.
85. Hanon E, Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 2001;10:287-293.
86. Edmonds HL Jr, Jiang YD, Zhang PY, Shank RP. Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sci 1996;59:PL127-131.
87. Kanda T, Kurokawa M, Tamura S, et al. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats. Life Sci 1996;59:1607-1616.
88. Yang Y, Shuaib A, Li Q, Siddiqui MM. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolisation. Brain Res 1998;804:169-176.
89. Schwab S, Spranger M, Schwarz S, Hacke W. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 1997;48:1608-1613.
90. Shapiro HM. Barbiturates in brain ischemia. Br J Anaesth 1985;57:82-95.
91. Traystman RJ, Klaus JA, DeVries AC, Shaivitz AB, Hurn PD. Anticonvulsant lamotrigine administered on reperfusion fails to improve experimental stroke outcome. Stroke 2001;32:783-787.
92. Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986;376:71-77.
93. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 1986;379:104-111.
94. Schallert T, Jones TA, Weaver MS, et al. Pharmacologic and anatomic considerations in recovery of function. Phys Med Rehab 1992;6:375-393.
95. Goldstein LB, Matchar DB, Morgenlander JC, Davis JN. Influence of drugs on the recovery of sensorimotor function after stroke. J Neurol Rehab 1990;4:137-144.
96. Goldstein LB. Common drugs may influence motor recovery after stroke. Neurology 1995;45:865-871.
97. Marson A, Jacoby A, Johnson A, et al. Medical Research Council MESS Study Group. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005;365:2007-2013.
98. Chandra B. First seizure in adults: to treat or not to treat. Clin Neurol Neurosurg 1992;94 (suppl):S61-63.
99. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group). Neurology 1993;43:478-483.
100. Gilad R, Lampl Y, Gabbay U, et al. Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol 1996;53:1149-1152.
101. Das CP, Sawhney IM, Lal V, Prabhakar S. Risk of recurrence of seizures following single unprovoked idiopathic seizure. Neurol India 2000;48:357-360.
102. Ryvlin P. When to start antiepileptic drug treatment: seize twice might not harm. Curr Opin Neurol 2006;19:154-156.
103. Hansen JM, Kristensen M, Skovsted DL, Christensen LK. Dicoumarol-induced diphenylhydantoin intoxication. Lancet 1966;2:265-266.
104. Chou RC, Levy G. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats. J Pharmacol Exp Ther 1981;219;1:42-48.
105. Fraser DG, Ludden TM, Evens RP, Sutherland EW. Displacement of phenytoin from plasma binding sites by salicylate. Clin Pharmacol Ther 1980;27:165-169.
106. Cucinell SA. Phenobarbital. Interactions with other drugs. In: Woodbury DM, Penry JK, Schmidt RP, eds. Antiepileptic drugs. New York: Raven Press, 1972:319-327.
107. Massey EW. Effect of carbamazepine on coumadin metabolism. Ann Neurol 1983;13:691-692.
108. Schlienger R, Kurmann M, Drewe J, Muller-Spahn F, Seifritz E. Inhibition of phenprocoumon anticoagulation by carbamazepine. Eur Neuropsychopharmacol 2000;10:219-221.
109. Bottcher T, Buchmann J, Zettl UK, Benecke R. Carbamazepine-phenprocoumon interaction. Eur Neurol 1997;38:132-133.
110. Denbow CE, Frazer HS. Clinically significant hemorrhage due to warfarin-carbamazepine interaction. South Med J 1990;83:981.
111. Fleitman JS, Bruni J, Perrin JH, Wilder BJ. Albumin-binding interactions of sodium valproate. J Clin Pharmacol 1980;20:8-9:514-517.
112. Kramer G, Tettenborn B, Klosterskov Jensen P, Menge GP, Stoll KD. Oxcarbazepine does not affect the anticoagulant activity of warfarin. Epilepsia 1992;33:1145-1148.
113. Ragueneau-Majlessi I, Levy RH, Meyerhoff C. Lack of effect of repeated administration of levitiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin. Epilepsy Res 2001;47:55-63.
114. Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001;42:357-362.
115. Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998;51:1256-1262.
116. Alvarez-Sabin J, Montaner J, Padro L, et al. Gabapentin in late-onset poststroke seizures. Neurology 2002;59:1991-1993.
117. Cameron H, Macphee GJ. Anticonvulsant therapy in the elderly - a need for placebo controlled trials. Epilepsy Res 1995;21:149-157.
118. Hasegawa H, Kanner AM. Seizure control after chronic pharmacotherapy in epileptic disorders beginning after 40 years of age. Clin Neuropharmacol 1995;18:13-22.
119. Craig I, Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994;35:381-390.
120. Giorgi L, Gomez G, O'Neill F, Hammer AE, Risner M. The tolerability of lamotrigine in elderly patients with epilepsy. Drugs Aging 2001;18:621-630.
121. Mauri Llerda JA, Tejero C, Mercade JM, Padro LL, Salas Puig J. Lamotrigine and epilepsy in the elderly: observational study of lowdose monotherapy. Int J Clin Pract 2005;59:651-654.
122. Ferrendelli JA, French J, Leppik I, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav 2003;4:702-709.
123. Groselj J, Guerrini R, Van Oene J, Lahaye M, Schreiner A, Schwalen S;TOP-INT-51 Investigators' Group. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurol Scand 2005;112:144-150.
124. Kutluay E, McCague K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003;4:175-180.
125. Brodie MJ, Mumford JP. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group. Epilepsy Res 1999;34:199-205.
126. Rowan AJ, Ramsay RE, Collins JF, et al., and the VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-1873.
127. Saetre E, Perucca E, Isojärvi J, Gjerstad L. An international multicenter double-blind double-dummy randomised trial comparing lamotrigine and slow-release carbamazepine for treating newly diagnosed epilepsy in the elderly. Proceedings of the 7th European Congress of Epileptology 2006:3.
128. Cloyd J, Hauser W, Towne A, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006;68(suppl 1):S39-48.
129. Gamble C, Williamson PR, Chadwick DW, Marson AG. A metaanalysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology 2006;66:1310-1317.
130. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-1120.
131. Ficker DM, Privitera M, Krauss G, et al. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine. Neurology 2005;65:593-595.
132. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ, for the Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007 (in press).